Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide.

Ying S. Zou, Stephanie R. Fink, Kimberly J. Stockero, Sarah F. Paternoster, Stephanie A. Smoley, Han W Tun, Craig B. Reeder, Ayalew Tefferi, Gordon W. Dewald

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In clinical practice, whether FISH for EGR1 in interphase nuclei has similar efficacy to detect deletion 5q anomalies as conventional cytogenetic studies is unknown. We compared conventional cytogenetics and FISH for 145 patients with deletion 5q and detected this anomaly by both methods in 144. Nine patients with myelodysplasia were studied before and after treatment with Lenalidomide and results were concordant for 28 of 29 specimens. FISH did not detect anomalies other than deletion 5q in 31 patients. This study suggests FISH is useful to detect deletion 5q, but is not a substitute for conventional cytogenetics.

Original languageEnglish (US)
Pages (from-to)1185-1189
Number of pages5
JournalLeukemia Research
Volume31
Issue number9
DOIs
StatePublished - Sep 2007

Fingerprint

Cytogenetics
Interphase
Therapeutics
lenalidomide

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide. / Zou, Ying S.; Fink, Stephanie R.; Stockero, Kimberly J.; Paternoster, Sarah F.; Smoley, Stephanie A.; Tun, Han W; Reeder, Craig B.; Tefferi, Ayalew; Dewald, Gordon W.

In: Leukemia Research, Vol. 31, No. 9, 09.2007, p. 1185-1189.

Research output: Contribution to journalArticle

Zou, Ying S. ; Fink, Stephanie R. ; Stockero, Kimberly J. ; Paternoster, Sarah F. ; Smoley, Stephanie A. ; Tun, Han W ; Reeder, Craig B. ; Tefferi, Ayalew ; Dewald, Gordon W. / Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide. In: Leukemia Research. 2007 ; Vol. 31, No. 9. pp. 1185-1189.
@article{a623d156b528481fb40c18212cd87d45,
title = "Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide.",
abstract = "In clinical practice, whether FISH for EGR1 in interphase nuclei has similar efficacy to detect deletion 5q anomalies as conventional cytogenetic studies is unknown. We compared conventional cytogenetics and FISH for 145 patients with deletion 5q and detected this anomaly by both methods in 144. Nine patients with myelodysplasia were studied before and after treatment with Lenalidomide and results were concordant for 28 of 29 specimens. FISH did not detect anomalies other than deletion 5q in 31 patients. This study suggests FISH is useful to detect deletion 5q, but is not a substitute for conventional cytogenetics.",
author = "Zou, {Ying S.} and Fink, {Stephanie R.} and Stockero, {Kimberly J.} and Paternoster, {Sarah F.} and Smoley, {Stephanie A.} and Tun, {Han W} and Reeder, {Craig B.} and Ayalew Tefferi and Dewald, {Gordon W.}",
year = "2007",
month = "9",
doi = "10.1016/j.leukres.2006.10.011",
language = "English (US)",
volume = "31",
pages = "1185--1189",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide.

AU - Zou, Ying S.

AU - Fink, Stephanie R.

AU - Stockero, Kimberly J.

AU - Paternoster, Sarah F.

AU - Smoley, Stephanie A.

AU - Tun, Han W

AU - Reeder, Craig B.

AU - Tefferi, Ayalew

AU - Dewald, Gordon W.

PY - 2007/9

Y1 - 2007/9

N2 - In clinical practice, whether FISH for EGR1 in interphase nuclei has similar efficacy to detect deletion 5q anomalies as conventional cytogenetic studies is unknown. We compared conventional cytogenetics and FISH for 145 patients with deletion 5q and detected this anomaly by both methods in 144. Nine patients with myelodysplasia were studied before and after treatment with Lenalidomide and results were concordant for 28 of 29 specimens. FISH did not detect anomalies other than deletion 5q in 31 patients. This study suggests FISH is useful to detect deletion 5q, but is not a substitute for conventional cytogenetics.

AB - In clinical practice, whether FISH for EGR1 in interphase nuclei has similar efficacy to detect deletion 5q anomalies as conventional cytogenetic studies is unknown. We compared conventional cytogenetics and FISH for 145 patients with deletion 5q and detected this anomaly by both methods in 144. Nine patients with myelodysplasia were studied before and after treatment with Lenalidomide and results were concordant for 28 of 29 specimens. FISH did not detect anomalies other than deletion 5q in 31 patients. This study suggests FISH is useful to detect deletion 5q, but is not a substitute for conventional cytogenetics.

UR - http://www.scopus.com/inward/record.url?scp=34548007948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548007948&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2006.10.011

DO - 10.1016/j.leukres.2006.10.011

M3 - Article

C2 - 17125835

AN - SCOPUS:34249905898

VL - 31

SP - 1185

EP - 1189

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 9

ER -